Categories Earnings, Health Care

Vertex Pharmaceuticals (VRTX): Q3 2019 Earnings Snapshot

— Vertex Pharmaceuticals (NASDAQ: VRTX) reported third-quarter 2019 earnings of $1.23 per share, vs. $1.15 per share expected

— Total revenue grew 21% to $949.8 million, vs $950.9 million expected.

— Reiterated FY19 product revenues guidance of $3.70 – 3.75 billion. Non-GAAP effective tax rate outlook was also unchanged at 21-22%.

— VRTX shares were down 0.14% immediately following the announcement.

Vertex Pharmaceuticals Q3 2019 Earnings Infographic

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CAG Earnings: Conagra Brands Q4 adj. profit drops, misses estimates

Conagra Brands, Inc. (NYSE: CAG), a leading provider of consumer packaged goods, reported lower sales and adjusted earnings for the fourth quarter of 2025. Results missed analysts' estimates. Net sales

Delta Air Lines (DAL) Q2 2025 Earnings: Key financials and quarterly highlights

Delta Air Lines (NYSE: DAL) reported its second quarter 2025 earnings results today. Operating revenue remained flat versus the year-ago quarter at $16.64 billion. GAAP net income increased 63% year-over-year

Bank earnings preview: These banking leaders will report Q2 2025 results next week, what to expect

The earnings season is set to kick off next week with quarterly reports from a number of leading banks. JPMorgan Chase & Co. (NYSE: JPM), Citigroup (NYSE: C) and Wells

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top